Please Select Search Type
Please Enter Keywords
Search
Please Select Search Type
Please Enter Keywords
Search
English
Global Human Rabies Vaccine Market Size, Competition Landscape and Supply Chain Research Report 2025

Global Human Rabies Vaccine Market Size, Competition Landscape and Supply Chain Research Report 2025

Published:2025-04-10
Pages:155
Tables and Figures:170
Report ID:WENKH000252
Report Format:
Delivery:48-72h
Select Type :
Full Report
Competitive Landscape
Select Version :
Single Users License:$ 3700
Buy Now
Request Sample
Custom Reports
Contact Us
Important Clause:
Recently, our company has discovered that some websites have plagiarized, quoted and modified our original report catalog without authorization, and sold reports under our brand, which has seriously infringed our interests. Therefore, our company recommends that you contact the relevant phone number, email address or leave a message to purchase the report to prevent being deceived.
*All report contents displayed on this website are original to WENKH, and our company has the sole copyright. Any modification, reprinting or quoting in any form is prohibited without our prior written permission. Otherwise, our company reserves the right to pursue legal responsibility.
Research Scope
Table of Contents
Tables and Figures
Full Report

Research Summary

The human rabies vaccine is a preventive measure against rabies, a deadly viral infection transmitted through the saliva of infected animals, primarily dogs. This vaccine induces active immunity by exposing the recipient's immune system to inactivated rabies virus particles. The standard rabies vaccination schedule involves multiple doses given over a few weeks, and booster shots are recommended for those at continued risk of exposure, such as veterinarians or travelers to regions where rabies is prevalent. The vaccine stimulates the production of antibodies, which can rapidly neutralize the virus if the person is later exposed. Post-exposure prophylaxis, including the rabies vaccine and human rabies immunoglobulin, is administered in the event of potential exposure to the virus, such as bites or scratches from animals suspected of being rabid. The human rabies vaccine has significantly contributed to the prevention of rabies, a disease that is almost universally fatal once clinical symptoms appear.

According to WENKH research statistics, the global Human Rabies Vaccine market size will reach 1,339.77 Million USD in 2025 and is projected to reach 1,885.19 Million USD by 2032, with a CAGR of 5.00% (2025-2032). Among them, the Asia-Pacific Human Rabies Vaccine market is undergoing rapid changes, reaching Million USD in 2025, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.

The global human rabies vaccine market is currently dominated by a relatively small group of well-established pharmaceutical players, each leveraging deep technical expertise, mature production capacity, and international regulatory compliance. Companies such as Sanofi, Bharat Biotech, and GlaxoSmithKline (GSK) have maintained strong market positions by offering a wide portfolio of rabies vaccines tailored for both pre- and post-exposure prophylaxis. Sanofi, for instance, continues to hold considerable market share through its Verorab product, known for broad global distribution and WHO prequalification. Meanwhile, Bharat Biotech has carved out significant presence in emerging markets, particularly in Asia and Africa, with its more affordable vaccine formulations.

That said, the competitive landscape is shifting, with Chinese vaccine manufacturers rising in influence, especially in domestic and regional markets. Backed by policy incentives and accelerated R&D, these players are becoming more prominent not only as low-cost suppliers but also as innovation-driven competitors.

The global Human Rabies Vaccine market is highly competitive, with key market players including Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, Ningbo Rongan Biological, ZhongKe Biopharm, Indian Immunologicals, etc. This report categorizes the competitive landscape of the global Human Rabies Vaccine market into three tiers based on annual revenue, with the top three market players holding approximately  % of the total market share.

This report provides an in-depth analysis of the global Human Rabies Vaccine market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, revenue, sales volume and gross profit margin of major manufacturers in the global Human Rabies Vaccine industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different segments of Human Rabies Vaccine and their downstream application fields.

In terms of data coverage, this report includes extensive time-series data. Historical data spans from 2020 to 2024, providing a solid foundation for analyzing market development trends. The year 2025 is used as a base year to accurately assess the current market landscape, while forecast data extends from 2026 to 2032, using scientific analysis methods and models to offer forward-looking projections and insights into the market's future trajectory. This provides valuable reference information for industry participants and stakeholders.

The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the revenue and sales volume of Human Rabies Vaccine in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Human Rabies Vaccine market. By considering local policies, this report evaluates the market prospects of Human Rabies Vaccine in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.

This report places significant emphasis on data quality and reliability, leveraging a wide range of data sources to ensure accuracy and validity. Primary data collection is conducted through multiple channels, including in-depth interviews with senior corporate executives, industry experts, supply chain participants, and end consumers. This helps to gain insights into corporate strategic planning, industry policies, supply chain dynamics, and user experiences. Secondary data sources cover an extensive range, including authoritative government statistics, customs databases, industry related reports, third-party paid databases, investment research reports, academic studies, corporate financial statements, real-time media updates, and information from international organizations, all of which serve as a solid foundation for data verification and analysis.

Companies Covered

Bharat Biotech

Bavarian Nordic

Sanofi-Pasteur

Chengda Bio

KANGH

Prcmise

Henan Grand Biopharma

Zhuoyi Biological

Ningbo Rongan Biological

ZhongKe Biopharm

Indian Immunologicals

Product Segment

Vero Cell

BHK

Chick Embryo Cell

Human Diploid Cells

Others

Product Application

Pre-Exposure Vaccine

Post-Exposure Vaccine


Chapter Scope

Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects

Chapter 2: Global Human Rabies Vaccine Industry Chain Analysis

Chapter 3: Global Human Rabies Vaccine Industry Environment Analysis and Porter's Five Forces Analysis

Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Human Rabies Vaccine Market (Market Share, Product Revenue and Sales Volume Comparison, Tier Division, Corporate Expansion and M&A Trends)

Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Sales Volume, Product Average Price, Product Gross Profit Margin and Geographical Sales Share)

Chapter 6: Global Human Rabies Vaccine Product Segment, Downstream Application and Major Regional Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 7: North America Human Rabies Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 8: Europe Human Rabies Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 9: China Human Rabies Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 10: Asia Pacific (excluding China) Human Rabies Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 11: Latin America Human Rabies Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 12: Middle East and Africa Human Rabies Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 13: Research Conclusion

Chapter 14: Methodology and Data Source


Purpose and Value of the Report

Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.

Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.

Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.

Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.

Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.

Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.

Table of Content

1 Human Rabies Vaccine Market Overview

   1.1 Product Definition Introduction

   1.2 Global Human Rabies Vaccine Market Size and Growth Forecast Analysis (2020-2032)

   1.3 Human Rabies Vaccine Market Status and Development Prospects

       1.3.1 Human Rabies Vaccine Market Status

       1.3.2 Human Rabies Vaccine Industry Development Prospects

   1.4 Human Rabies Vaccine Market Overview by Product Segment

       1.4.1 Global Human Rabies Vaccine Market Size and Growth Forecast Analysis by Product Segment: 2020 VS 2025 VS 2032

       1.4.2 Vero Cell

       1.4.3 BHK

       1.4.4 Chick Embryo Cell

       1.4.5 Human Diploid Cells

       1.4.6 Others

   1.5 Human Rabies Vaccine Market Overview by Product Application

       1.5.1 Global Human Rabies Vaccine Market Size and Growth Forecast Analysis by Product Application: 2020 VS 2025 VS 2032

       1.5.2 Pre-Exposure Vaccine

       1.5.3 Post-Exposure Vaccine

2 Human Rabies Vaccine Industry Supply Chain Analysis

   2.1 Human Rabies Vaccine Supply Chain

   2.2 Human Rabies Vaccine Industry Upstream Supply Analysis

       2.2.1 Upstream Raw Materials Supply Status

       2.2.2 Key Raw Material Suppliers

   2.3 Human Rabies Vaccine Midstream Manufacturers

   2.4 Human Rabies Vaccine Downstream Customers

   2.5 Human Rabies Vaccine Sales Channel Analysis

3 Human Rabies Vaccine Market Environment Analysis

   3.1 Human Rabies Vaccine Industry Policy Analysis

   3.2 Human Rabies Vaccine Emerging Technology Trends in the Industry

   3.3 Human Rabies Vaccine Restraining Factors Analysis

   3.4 Human Rabies Vaccine Market Porter's Five Forces Analysis

       3.4.1 Competitive Rivalry

       3.4.2 Threat of New Entrants

       3.4.3 Bargaining Power of Suppliers

       3.4.4 Bargaining Power of Buyers

       3.4.5 Threat of Substitute Products or Services

4 Global Human Rabies Vaccine Manufacturer Competition Landscape

   4.1 Global Human Rabies Vaccine Market Sales Volume, Revenue by Key Manufacturers (2021-2025)

       4.1.1 Global Human Rabies Vaccine Market Sales Volume by Key Manufacturers (2021-2025)

       4.1.2 Global Human Rabies Vaccine Market Revenue by Key Manufacturers (2021-2025)

   4.2 Global Human Rabies Vaccine Market Position by Key Manufacturers

   4.3 China Human Rabies Vaccine Market Position by Key Manufacturers

   4.4 Global Key Manufacturers Headquarter and Key Area Served

   4.5 Global Human Rabies Vaccine Market Expansion and M&A Dynamic

5 In-depth Analysis of Key Players

   5.1 Bharat Biotech

       5.1.1 Bharat Biotech Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.1.2 Bharat Biotech Human Rabies Vaccine Product Features

       5.1.3 Bharat Biotech Human Rabies Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.1.4 Bharat Biotech Human Rabies Vaccine Revenue by Product Segment

       5.1.5 Bharat Biotech Human Rabies Vaccine Revenue by Region

   5.2 Bavarian Nordic

       5.2.1 Bavarian Nordic Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.2.2 Bavarian Nordic Human Rabies Vaccine Product Features

       5.2.3 Bavarian Nordic Human Rabies Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.2.4 Bavarian Nordic Human Rabies Vaccine Revenue by Product Segment

       5.2.5 Bavarian Nordic Human Rabies Vaccine Revenue by Region

   5.3 Sanofi-Pasteur

       5.3.1 Sanofi-Pasteur Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.3.2 Sanofi-Pasteur Human Rabies Vaccine Product Features

       5.3.3 Sanofi-Pasteur Human Rabies Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.3.4 Sanofi-Pasteur Human Rabies Vaccine Revenue by Product Segment

       5.3.5 Sanofi-Pasteur Human Rabies Vaccine Revenue by Region

   5.4 Chengda Bio

       5.4.1 Chengda Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.4.2 Chengda Bio Human Rabies Vaccine Product Features

       5.4.3 Chengda Bio Human Rabies Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.4.4 Chengda Bio Human Rabies Vaccine Revenue by Product Segment

       5.4.5 Chengda Bio Human Rabies Vaccine Revenue by Region

   5.5 KANGH

       5.5.1 KANGH Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.5.2 KANGH Human Rabies Vaccine Product Features

       5.5.3 KANGH Human Rabies Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.5.4 KANGH Human Rabies Vaccine Revenue by Product Segment

       5.5.5 KANGH Human Rabies Vaccine Revenue by Region

   5.6 Prcmise

       5.6.1 Prcmise Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.6.2 Prcmise Human Rabies Vaccine Product Features

       5.6.3 Prcmise Human Rabies Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.6.4 Prcmise Human Rabies Vaccine Revenue by Product Segment

       5.6.5 Prcmise Human Rabies Vaccine Revenue by Region

   5.7 Henan Grand Biopharma

       5.7.1 Henan Grand Biopharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.7.2 Henan Grand Biopharma Human Rabies Vaccine Product Features

       5.7.3 Henan Grand Biopharma Human Rabies Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.7.4 Henan Grand Biopharma Human Rabies Vaccine Revenue by Product Segment

       5.7.5 Henan Grand Biopharma Human Rabies Vaccine Revenue by Region

   5.8 Zhuoyi Biological

       5.8.1 Zhuoyi Biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.8.2 Zhuoyi Biological Human Rabies Vaccine Product Features

       5.8.3 Zhuoyi Biological Human Rabies Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.8.4 Zhuoyi Biological Human Rabies Vaccine Revenue by Product Segment

       5.8.5 Zhuoyi Biological Human Rabies Vaccine Revenue by Region

   5.9 Ningbo Rongan Biological

       5.9.1 Ningbo Rongan Biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.9.2 Ningbo Rongan Biological Human Rabies Vaccine Product Features

       5.9.3 Ningbo Rongan Biological Human Rabies Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.9.4 Ningbo Rongan Biological Human Rabies Vaccine Revenue by Product Segment

       5.9.5 Ningbo Rongan Biological Human Rabies Vaccine Revenue by Region

   5.10 ZhongKe Biopharm

       5.10.1 ZhongKe Biopharm Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.10.2 ZhongKe Biopharm Human Rabies Vaccine Product Features

       5.10.3 ZhongKe Biopharm Human Rabies Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.10.4 ZhongKe Biopharm Human Rabies Vaccine Revenue by Product Segment

       5.10.5 ZhongKe Biopharm Human Rabies Vaccine Revenue by Region

   5.11 Indian Immunologicals

       5.11.1 Indian Immunologicals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.11.2 Indian Immunologicals Human Rabies Vaccine Product Features

       5.11.3 Indian Immunologicals Human Rabies Vaccine Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.11.4 Indian Immunologicals Human Rabies Vaccine Revenue by Product Segment

       5.11.5 Indian Immunologicals Human Rabies Vaccine Revenue by Region

6 Global Human Rabies Vaccine Market Analysis by Regions, by Product Segment and Application

   6.1 Global Human Rabies Vaccine Market Size and Growth Forecast by Region: 2020 VS 2025 VS 2032

       6.1.1 Global Human Rabies Vaccine Market Revenue by Region (2020-2025)

       6.1.2 Global Human Rabies Vaccine Market Revenue Forecast by Region (2026-2032)

   6.2 Global Human Rabies Vaccine Market Sales Volume Analysis

       6.2.1 Global Human Rabies Vaccine Market Sales Volume by Region (2020-2025)

       6.2.2 Global Human Rabies Vaccine Market Sales Volume Forecast by Region (2026-2032)

   6.3 Global Human Rabies Vaccine Market by Product Segment (2020-2032)

       6.3.1 Global Human Rabies Vaccine Market Revenue and Forecast by Product Segment

       6.3.2 Global Human Rabies Vaccine Market Sales Volume and Forecast by Product Segment

   6.4 Global Human Rabies Vaccine Market by Product Application (2020-2032)

       6.4.1 Global Human Rabies Vaccine Market Revenue and Forecast by Product Application

       6.4.2 Global Human Rabies Vaccine Market Sales Volume and Forecast by Product Application

7 North America Human Rabies Vaccine Market Analysis

   7.1 North America Human Rabies Vaccine Market Prospects

       7.1.1 North America Human Rabies Vaccine Market Revenue and Growth Forecast by Countries (2020-2032)

       7.1.2 North America Human Rabies Vaccine Sales Volume and Growth Forecast by Countries (2020-2032)

       7.1.3 U.S.

       7.1.4 Canada

   7.2 North America Human Rabies Vaccine Market by Product Segment (2020-2032)

       7.2.1 North America Human Rabies Vaccine Market Revenue and Forecast Analysis by Product Segment

       7.2.2 North America Human Rabies Vaccine Market Sales Volume and Forecast Analysis by Product Segment

   7.3 North America Human Rabies Vaccine Market by Product Application (2020-2032)

       7.3.1 North America Human Rabies Vaccine Market Revenue and Forecast Analysis by Product Application

       7.3.2 North America Human Rabies Vaccine Market Sales Volume and Forecast Analysis by Product Application

8 Europe Human Rabies Vaccine Market Analysis

   8.1 Europe Human Rabies Vaccine Market Prospects

       8.1.1 Europe Human Rabies Vaccine Market Revenue and Growth Forecast by Countries (2020-2032)

       8.1.2 Europe Human Rabies Vaccine Sales Volume and Growth Forecast by Countries (2020-2032)

       8.1.3 Germany

       8.1.4 France

       8.1.5 United Kingdom

       8.1.6 Italy

       8.1.7 Spain

       8.1.8 Benelux

   8.2 Europe Human Rabies Vaccine Market by Product Segment (2020-2032)

       8.2.1 Europe Human Rabies Vaccine Market Revenue and Forecast Analysis by Product Segment

       8.2.2 Europe Human Rabies Vaccine Market Sales Volume and Forecast Analysis by Product Segment

   8.3 Europe Human Rabies Vaccine Market by Product Application (2020-2032)

       8.3.1 Europe Human Rabies Vaccine Market Revenue and Forecast Analysis by Product Application

       8.3.2 Europe Human Rabies Vaccine Market Sales Volume and Forecast Analysis by Product Application

9 China Human Rabies Vaccine Market Analysis

   9.1 China Human Rabies Vaccine Market Prospects

       9.1.1 China Human Rabies Vaccine Revenue and Growth Forecast (2020-2032)

       9.1.2 China Human Rabies Vaccine Market Sales Volume and Growth Forecast (2020-2032)

   9.2 China Human Rabies Vaccine Market by Product Segment (2020-2032)

       9.2.1 China Human Rabies Vaccine Market Revenue and Forecast Analysis by Product Segment

       9.2.2 China Human Rabies Vaccine Market Sales Volume and Forecast Analysis by Product Segment

   9.3 China Human Rabies Vaccine Market by Product Application (2020-2032)

       9.3.1 China Human Rabies Vaccine Market Revenue and Forecast Analysis by Product Application

       9.3.2 China Human Rabies Vaccine Market Sales Volume and Forecast Analysis by Product Application

10 Asia Pacific (excl. China) Human Rabies Vaccine Market Analysis

   10.1 Asia Pacific (excl. China) Human Rabies Vaccine Market Prospects

       10.1.1 Asia Pacific (excl. China) Human Rabies Vaccine Revenue and Growth Forecast by Countries (2020-2032)

       10.1.2 Asia Pacific (excl. China) Human Rabies Vaccine Sales Volume and Growth Forecast by Countries (2020-2032)

       10.1.3 Japan

       10.1.4 South Korea

       10.1.5 India

       10.1.6 Southeast Asia

       10.1.7 Australia

   10.2 Asia Pacific (excl. China) Human Rabies Vaccine Market by Product Segment (2020-2032)

       10.2.1 Asia Pacific (excl. China) Human Rabies Vaccine Market Revenue and Forecast Analysis by Product Segment

       10.2.2 Asia Pacific (excl. China) Human Rabies Vaccine Market Sales Volume and Forecast Analysis by Product Segment

   10.3 Asia Pacific (excl. China) Human Rabies Vaccine Market by Product Application (2020-2032)

       10.3.1 Asia Pacific (excl. China) Human Rabies Vaccine Market Revenue and Forecast Analysis by Product Application

       10.3.2 Asia Pacific (excl. China) Human Rabies Vaccine Market Sales Volume and Forecast Analysis by Product Application

11 Latin America Human Rabies Vaccine Market Analysis

   11.1 Latin America Human Rabies Vaccine Market Prospects

       11.1.1 Latin America Human Rabies Vaccine Revenue and Growth Forecast by Countries (2020-2032)

       11.1.2 Latin America Human Rabies Vaccine Sales Volume and Growth Forecast by Countries (2020-2032)

       11.1.3 Mexico

       11.1.4 Brazil

   11.2 Latin America Human Rabies Vaccine Market by Product Segment (2020-2032)

       11.2.1 Latin America Human Rabies Vaccine Market Revenue and Forecast Analysis by Product Segment

       11.2.2 Latin America Human Rabies Vaccine Market Sales Volume and Forecast Analysis by Product Segment

   11.3 Latin America Human Rabies Vaccine Market by Product Application (2020-2032)

       11.3.1 Latin America Human Rabies Vaccine Market Revenue and Forecast Analysis by Product Application

       11.3.2 Latin America Human Rabies Vaccine Market Sales Volume and Forecast Analysis by Product Application

12 Middle East and Africa Human Rabies Vaccine Market Analysis

   12.1 Middle East and Africa Human Rabies Vaccine Market Prospects

       12.1.1 Middle East and Africa Human Rabies Vaccine Revenue and Growth Forecast by Countries (2020-2032)

       12.1.2 Middle East and Africa Human Rabies Vaccine Sales Volume and Growth Forecast by Countries (2020-2032)

       12.1.3 Saudi Arabia

       12.1.4 South Africa

   12.2 Middle East and Africa Human Rabies Vaccine Market by Product Segment (2020-2032)

       12.2.1 Middle East and Africa Human Rabies Vaccine Market Revenue and Forecast Analysis by Product Segment

       12.2.2 Middle East and Africa Human Rabies Vaccine Market Sales Volume and Forecast Analysis by Product Segment

   12.3 Middle East and Africa Human Rabies Vaccine Market by Product Application (2020-2032)

       12.3.1 Middle East and Africa Human Rabies Vaccine Market Revenue and Forecast Analysis by Product Application

       12.3.2 Middle East and Africa Human Rabies Vaccine Market Sales Volume and Forecast Analysis by Product Application

13 Research Conclusion

14 Appendix

   14.1 Methodology/Research Approach

   14.2 Research Landscape

   14.3 Research Benchmark and Hypothesis

   14.4 Data Source

       14.4.1 Primary Sources

       14.4.2 Secondary Sources

   14.5 Data Cross Validation

   14.6 Disclaimer

image.png

Table 1:Global Human Rabies Vaccine Product Segment Market Size and Growth Forecast Analysis (2020 VS 2025 VS 2032) & (Million USD)

Table 2:Global Human Rabies Vaccine Market Size and Growth Forecast Analysis by Application (2020 VS 2025 VS 2032) & (Million USD)

Table 3:Key Raw Materials and Market Concentration

Table 4:Human Rabies Vaccine Raw Material Suppliers and Contact Information

Table 5:Human Rabies Vaccine Downstream Customers List

Table 6:Human Rabies Vaccine Distributors/Dealers List

Table 7:Global Human Rabies Vaccine Market Sales Volume by Key Manufacturers (2021-2025) & (K Doses)

Table 8:Global Human Rabies Vaccine Market Revenue by Key Manufacturers (2021-2025) & (Million USD)

Table 9:Global Human Rabies Vaccine Market Position by Key Manufacturers

Table 10:China Human Rabies Vaccine Market Position by Key Manufacturers

Table 11:Global Key Manufacturers Headquarter and Key Area Served

Table 12:Global Human Rabies Vaccine Market Expansion and M&A Dynamic

Table 13:Bharat Biotech Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 14:Bharat Biotech Human Rabies Vaccine Product Features

Table 15:Bharat Biotech Human Rabies Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2025)

Table 16:Bharat Biotech Human Rabies Vaccine Revenue by Product Segment

Table 17:Bharat Biotech Human Rabies Vaccine Revenue by Region

Table 18:Bavarian Nordic Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 19:Bavarian Nordic Human Rabies Vaccine Product Features

Table 20:Bavarian Nordic Human Rabies Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2025)

Table 21:Bavarian Nordic Human Rabies Vaccine Revenue by Product Segment

Table 22:Bavarian Nordic Human Rabies Vaccine Revenue by Region

Table 23:Sanofi-Pasteur Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 24:Sanofi-Pasteur Human Rabies Vaccine Product Features

Table 25:Sanofi-Pasteur Human Rabies Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2025)

Table 26:Sanofi-Pasteur Human Rabies Vaccine Revenue by Product Segment

Table 27:Sanofi-Pasteur Human Rabies Vaccine Revenue by Region

Table 28:Chengda Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 29:Chengda Bio Human Rabies Vaccine Product Features

Table 30:Chengda Bio Human Rabies Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2025)

Table 31:Chengda Bio Human Rabies Vaccine Revenue by Product Segment

Table 32:Chengda Bio Human Rabies Vaccine Revenue by Region

Table 33:KANGH Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 34:KANGH Human Rabies Vaccine Product Features

Table 35:KANGH Human Rabies Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2025)

Table 36:KANGH Human Rabies Vaccine Revenue by Product Segment

Table 37:KANGH Human Rabies Vaccine Revenue by Region

Table 38:Prcmise Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 39:Prcmise Human Rabies Vaccine Product Features

Table 40:Prcmise Human Rabies Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2025)

Table 41:Prcmise Human Rabies Vaccine Revenue by Product Segment

Table 42:Prcmise Human Rabies Vaccine Revenue by Region

Table 43:Henan Grand Biopharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 44:Henan Grand Biopharma Human Rabies Vaccine Product Features

Table 45:Henan Grand Biopharma Human Rabies Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2025)

Table 46:Henan Grand Biopharma Human Rabies Vaccine Revenue by Product Segment

Table 47:Henan Grand Biopharma Human Rabies Vaccine Revenue by Region

Table 48:Zhuoyi Biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 49:Zhuoyi Biological Human Rabies Vaccine Product Features

Table 50:Zhuoyi Biological Human Rabies Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2025)

Table 51:Zhuoyi Biological Human Rabies Vaccine Revenue by Product Segment

Table 52:Zhuoyi Biological Human Rabies Vaccine Revenue by Region

Table 53:Ningbo Rongan Biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 54:Ningbo Rongan Biological Human Rabies Vaccine Product Features

Table 55:Ningbo Rongan Biological Human Rabies Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2025)

Table 56:Ningbo Rongan Biological Human Rabies Vaccine Revenue by Product Segment

Table 57:Ningbo Rongan Biological Human Rabies Vaccine Revenue by Region

Table 58:ZhongKe Biopharm Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 59:ZhongKe Biopharm Human Rabies Vaccine Product Features

Table 60:ZhongKe Biopharm Human Rabies Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2025)

Table 61:ZhongKe Biopharm Human Rabies Vaccine Revenue by Product Segment

Table 62:ZhongKe Biopharm Human Rabies Vaccine Revenue by Region

Table 63:Indian Immunologicals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 64:Indian Immunologicals Human Rabies Vaccine Product Features

Table 65:Indian Immunologicals Human Rabies Vaccine Product Revenue (Million USD), Sales Volume (K Doses), Price (USD/Dose) and Gross Margin (2021-2025)

Table 66:Indian Immunologicals Human Rabies Vaccine Revenue by Product Segment

Table 67:Indian Immunologicals Human Rabies Vaccine Revenue by Region

Table 68:Global Human Rabies Vaccine Market Size and Growth Forecast by Region (2020 VS 2025 VS 2032) & (Million USD)

Table 69:Global Human Rabies Vaccine Market Revenue by Region (2020-2025) & (Million USD)

Table 70:Global Human Rabies Vaccine Market Share by Region (2020-2025)

Table 71:Global Human Rabies Vaccine Market Revenue Forecast by Region (2026-2032) & (Million USD)

Table 72:Global Human Rabies Vaccine Market Share Forecast by Region (2026-2032)

Table 73:Global Human Rabies Vaccine Market Sales by Region (2020-2025) & (K Doses)

Table 74:Global Human Rabies Vaccine Sales Volume Market Share by Region (2020-2025)

Table 75:Global Human Rabies Vaccine Market Sales Volume Forecast by Region (2026-2032) & (K Doses)

Table 76:Global Human Rabies Vaccine Sales Volume Market Share Forecast by Region (2026-2032)

Table 77:Global Human Rabies Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 78:Global Human Rabies Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 79:Global Human Rabies Vaccine Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 80:Global Human Rabies Vaccine Market Sales Volume Forecast by Product Segment (2026-2032) & (K Doses)

Table 81:Global Human Rabies Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)

Table 82:Global Human Rabies Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 83:Global Human Rabies Vaccine Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 84:Global Human Rabies Vaccine Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 85:North America Human Rabies Vaccine Market Revenue by Countries (2020-2025) & (Million USD)

Table 86:North AmericaHuman Rabies Vaccine Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 87:North America Human Rabies Vaccine Market Sales Volume by Countries (2020-2025) & K Doses)

Table 88:North America Human Rabies Vaccine Market Sales Volume Forecast by Countries (2026-2032) & (K Doses)

Table 89:North America Human Rabies Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 90:North America Human Rabies Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 91:North America Human Rabies Vaccine Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 92:North America Human Rabies Vaccine Market Sales Volume Forecast by Segment (2026-2032) & (K Doses)

Table 93:North America Human Rabies Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)

Table 94:North America Human Rabies Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 95:North America Human Rabies Vaccine Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 96:North America Human Rabies Vaccine Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 97:Europe Human Rabies Vaccine Market Revenue by Countries (2020-2025) & (Million USD)

Table 98:Europe Human Rabies Vaccine Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 99:Europe Human Rabies Vaccine Market Sales Volume by Countries (2020-2025) & (K Doses)

Table 100:Europe Human Rabies Vaccine Market Sales Volume Forecast by Countries (2026-2032) & (K Doses)

Table 101:Europe Human Rabies Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 102:Europe Human Rabies Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 103:Europe Human Rabies Vaccine Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 104:Europe Human Rabies Vaccine Market Sales Volume Forecast by Segment (2026-2032) & (K Doses)

Table 105:Europe Human Rabies Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)

Table 106:Europe Human Rabies Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 107:Europe Human Rabies Vaccine Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 108:Europe Human Rabies Vaccine Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 109:China Human Rabies Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 110:China Human Rabies Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 111:China Human Rabies Vaccine Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 112:China Human Rabies Vaccine Market Sales Volume Forecast by Segment (2026-2032) & (K Doses)

Table 113:China Human Rabies Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)

Table 114:China Human Rabies Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 115:China Human Rabies Vaccine Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 116:China Human Rabies Vaccine Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 117:Asia Pacific (excl. China) Human Rabies Vaccine Market Revenue by Countries (2020-2025) & (Million USD)

Table 118:Asia Pacific (excl. China) Human Rabies Vaccine Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 119:Asia Pacific (excl. China) Human Rabies Vaccine Market Sales Volume by Countries (2020-2025) & (K Doses)

Table 120:Asia Pacific (excl. China) Human Rabies Vaccine Market Sales Volume Forecast by Countries (2026-2032) & (K Doses)

Table 121:Asia Pacific (excl. China) Human Rabies Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 122:Asia Pacific (excl. China) Human Rabies Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 123:Asia Pacific (excl. China) Human Rabies Vaccine Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 124:Asia Pacific (excl. China) Human Rabies Vaccine Market Sales Volume Forecast by Segment (2026-2032) & (K Doses)

Table 125:Asia Pacific (excl. China) Human Rabies Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)

Table 126:Asia Pacific (excl. China) Human Rabies Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 127:Asia Pacific (excl. China) Human Rabies Vaccine Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 128:Asia Pacific (excl. China) Human Rabies Vaccine Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 129:Latin America Human Rabies Vaccine Market Revenue by Countries (2020-2025) & (Million USD)

Table 130:Latin America Human Rabies Vaccine Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 131:Latin America Human Rabies Vaccine Market Sales Volume by Countries (2020-2025) & (K Doses)

Table 132:Latin America Human Rabies Vaccine Market Sales Volume Forecast by Countries (2026-2032) & (K Doses)

Table 133:Latin America Human Rabies Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 134:Latin America Human Rabies Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 135:Latin America Human Rabies Vaccine Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 136:Latin America Human Rabies Vaccine Market Sales Volume Forecast by Segment (2026-2032) & (K Doses)

Table 137:Latin America Human Rabies Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)

Table 138:Latin America Human Rabies Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 139:Latin America Human Rabies Vaccine Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 140:Latin America Human Rabies Vaccine Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 141:Middle East and Africa Human Rabies Vaccine Market Revenue by Countries (2020-2025) & (Million USD)

Table 142:Middle East and Africa Human Rabies Vaccine Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 143:Middle East and Africa Human Rabies Vaccine Market Sales Volume by Countries (2020-2025) & (K Doses)

Table 144:Middle East and Africa Human Rabies Vaccine Market Sales Volume Forecast by Countries (2026-2032) & (K Doses)

Table 145:Middle East and Africa Human Rabies Vaccine Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 146:Middle East and Africa Human Rabies Vaccine Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 147:Middle East and Africa Human Rabies Vaccine Market Sales Volume by Product Segment (2020-2025) & (K Doses)

Table 148:Middle East and Africa Human Rabies Vaccine Market Sales Volume Forecast by Segment (2026-2032) & (K Doses)

Table 149:Middle East and Africa Human Rabies Vaccine Market Revenue by Product Application (2020-2025) & (Million USD)

Table 150:Middle East and Africa Human Rabies Vaccine Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 151:Middle East and Africa Human Rabies Vaccine Market Sales Volume by Product Application (2020-2025) & (K Doses)

Table 152:Middle East and Africa Human Rabies Vaccine Market Sales Volume Forecast by Product Application (2026-2032) & (K Doses)

Table 153:Secondary Sources


image.png

Figure 1:Human Rabies Vaccine Product Scope

Figure 2:Global Human Rabies Vaccine Market Size and Growth Forecast Analysis (2020-2032) & (Million USD)

Figure 3:Global Human Rabies Vaccine Sales Volume and Growth Forecast Analysis (2020-2032) & (K Doses)

Figure 4:Global Human Rabies Vaccine Product Segment Market Share (2025 & 2032)

Figure 5:Global Human Rabies Vaccine Product Application Market Share (2025 & 2032)

Figure 6:Vero Cell Product Scope

Figure 7:BHK Product Scope

Figure 8:Chick Embryo Cell Product Scope

Figure 9:Human Diploid Cells Product Scope

Figure 10:Others Product Scope

Figure 11:Pre-Exposure Vaccine Product Scope

Figure 12:Post-Exposure Vaccine Product Scope

Figure 13:Human Rabies Vaccine Industrial Chain Framework

Figure 14:Global Human Rabies Vaccine Market by Geographic Segmentation in 2025

Figure 15:Global Human Rabies Vaccine Market Share by Region (2020 VS 2025)

Figure 16:Global Human Rabies Vaccine Sales Volume Market Share by Region (2020 VS 2025)

Figure 17:North America Human Rabies Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 18:North America Human Rabies Vaccine Revenue Market Share by Countries (2025 VS 2032)

Figure 19:North America Human Rabies Vaccine Sales Volume Market Share by Countries (2025 VS 2032)

Figure 20:U.S. Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 21:U.S. Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 22:Canada Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 23:Canada Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 24:Europe Human Rabies Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 25:Europe Human Rabies Vaccine Revenue Market Share by Countries (2025 VS 2032)

Figure 26:Europe Human Rabies Vaccine Sales Volume Market Share by Countries (2025 VS 2032)

Figure 27:Germany Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 28:Germany Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 29:France Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 30:France Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 31:United Kingdom Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 32:United Kingdom Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 33:Italy Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 34:Italy Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 35:Spain Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 36:Spain Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 37:Benelux Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 38:Benelux Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 39:China Human Rabies Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 40:China Human Rabies Vaccine Market Sales Volume and Growth Forecast (K Doses)

Figure 41:Asia Pacific (excl. China) Human Rabies Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 42:Asia Pacific (excl. China) Human Rabies Vaccine Revenue Market Share by Countries (2025 VS 2032)

Figure 43:Asia Pacific (excl. China) Human Rabies Vaccine Sales Volume Market Share by Countries (2025 VS 2032)

Figure 44:Japan Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 45:Japan Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 46:South Korea Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 47:South Korea Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 48:India Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 49:India Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 50:Southeast Asia Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 51:Southeast Asia Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 52:Australia Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 53:Australia Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 54:Latin America Human Rabies Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 55:Latin America Human Rabies Vaccine Revenue Market Share by Countries (2025 VS 2032)

Figure 56:Latin America Human Rabies Vaccine Sales Volume Market Share by Countries (2025 VS 2032)

Figure 57:Mexico Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 58:Mexico Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 59:Brazil Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 60:Brazil Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 61:Middle East and Africa Human Rabies Vaccine Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 62:Middle East and Africa Human Rabies Vaccine Revenue Market Share by Countries (2025 VS 2032)

Figure 63:Middle East and Africa Human Rabies Vaccine Sales Volume Market Share by Countries (2025 VS 2032)

Figure 64:Saudi Arabia Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 65:Saudi Arabia Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 66:South Africa Human Rabies Vaccine Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 67:South Africa Human Rabies Vaccine Market Sales Volume and Forecast (2020-2032) & (K Doses)

Figure 68:Research Methodology

Figure 69:Primary Sources

Figure 70:Data Cross Validation

Global Human Rabies Vaccine Revenue and Market Share by Key Players

Revenue (US$ Million)20202021202220232024
Bharat BiotechXXXXXXXXXX
Bavarian NordicXXXXXXXXXX
Sanofi-PasteurXXXXXXXXXX
Chengda BioXXXXXXXXXX
KANGHXXXXXXXXXX
PrcmiseXXXXXXXXXX
Henan Grand BiopharmaXXXXXXXXXX
Zhuoyi BiologicalXXXXXXXXXX
Ningbo Rongan BiologicalXXXXXXXXXX
ZhongKe BiopharmXXXXXXXXXX
Indian ImmunologicalsXXXXXXXXXX
Other CompaniesXXXXXXXXXX
TotalXXXXXXXXXX


image.png


Global Human Rabies Vaccine Sales Volume and Market Share by Key Players

Sales (K Doses)20202021202220232024
Bharat BiotechXXXXXXXXXX
Bavarian NordicXXXXXXXXXX
Sanofi-PasteurXXXXXXXXXX
Chengda BioXXXXXXXXXX
KANGHXXXXXXXXXX
PrcmiseXXXXXXXXXX
Henan Grand BiopharmaXXXXXXXXXX
Zhuoyi BiologicalXXXXXXXXXX
Ningbo Rongan BiologicalXXXXXXXXXX
ZhongKe BiopharmXXXXXXXXXX
Indian ImmunologicalsXXXXXXXXXX
Other CompaniesXXXXXXXXXX
TotalXXXXXXXXXX


image.png


How to Order
Contact
Fill in your contact information, and the company will quickly match the specialist to get in touch with you
You can also directly call our customer service hotline or add customer service WeChat
Samples
One on one business specialist will send the complete version of the sample
If you need to customize the report, professional analysts will be arranged to communicate with you one-on-one and provide you with customized samples
Payment
Both parties sign a report purchase contract
Support Paypal, Visa, UnionPay and MasterCard Payment
Delivery
PDF report (sent online 2-3 working days after payment)
WORD version report (sent online 2-3 working days after payment)
Paper version report (sent via EMS or DHL within 3-5 working days after payment)
After-Sales
Within six months of purchasing the report, if you have any questions about the details of our report, you can contact the report analyst at any time. The analyst will continue to follow up and solve your problem until you are satisfied
No Relevant Report Found? Please Contact Us
Custom Reports
WENKH is a global leading consulting brand for industry segments. We provide segmented market research reports, custom research, white papers and feasibility reports for all industries, focusing on market status and forecasts, competition analysis, market prospects analysis and market positioning. WENKH uses professional data and deep insights to help companies make decisions and promote win-win cooperation.
Contact Us
Ocean Tower, No.145, Hong Kong Road, Wuhan City, Hube Province, China
Copyright © WENKH.com All rights reserved.